Dr D Prabakaran

Dr. Prabakaran is doctorate in pharmaceutical sciences from Dr. Hari Singh Gour University, Sagar, MP, and he started his career as formulation scientist in 2004. In 2006, he moved into clinical research and served generic pharmaceutical industry (Including Cadila Healthcare Ltd, Lupin Limited and Endo Pharmaceuticals) for 17 years in the area of formulation sciences, bioequivalence, late phase clinical studies, biopharmaceutics, in vitro-in vivo correlation, biostatistics, in vitro bioequivalence studies, clinical studies of derma, ophthalmic & pulmonary products, analytical and bioanalytical sciences. His experience with respect to clinical research/in vitro studies entirely with regulated market like US, Europe, Australia, etc., and faced various regulatory audits. He is well versed with the regulatory expectations and up to date with regulatory guidance and newer approaches on generic drug development. He has published many research articles in peer reviewed journals. He is currently associated with Invitro Research Solutions Private Limited at the capacity of Vice President managing analytical development and clinical research.